0001683168-24-001134.txt : 20240222
0001683168-24-001134.hdr.sgml : 20240222
20240222190012
ACCESSION NUMBER: 0001683168-24-001134
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240222
DATE AS OF CHANGE: 20240222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bitterman Robert J
CENTRAL INDEX KEY: 0001304395
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36304
FILM NUMBER: 24666729
MAIL ADDRESS:
STREET 1: C/O RXI PHARMACEUTICALS CORPORATION
STREET 2: 1500 WEST PARK DRIVE, SUITE 210
CITY: WESTBOROUGH
STATE: MA
ZIP: 01581
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp.
CENTRAL INDEX KEY: 0001533040
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
BUSINESS PHONE: (508) 767-3861
MAIL ADDRESS:
STREET 1: 257 SIMARANO DRIVE
STREET 2: SUITE 101
CITY: MARLBOROUGH
STATE: MA
ZIP: 01752
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20111019
4
1
ownership.xml
X0508
4
2024-02-20
0
0001533040
Phio Pharmaceuticals Corp.
PHIO
0001304395
Bitterman Robert J
C/O PHIO PHARMACEUTICALS CORP.
257 SIMARANO DRIVE, SUITE 101
MARLBOROUGH
MA
01752
1
1
0
0
President & CEO
0
Common stock, $0.0001 par value
2024-02-20
4
F
0
1804
0.76
D
16490
D
The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
Includes shares of common stock underlying unvested restricted stock units.
/s/ Caitlin Kontulis, attorney-in-fact
2024-02-22